Clinical Trial Update: A Phase II Study Evaluating the Efficacy and Safety of XH-S003 Capsules in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating the efficacy and safety of XH-S003 capsules in patients with paroxysmal nocturnal hemoglobinuria, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• XH-S003 Capsules

Snippet

Sponsor: S-INFINITY Pharmaceuticals Co., Ltd | Conditions: PNH - Paroxysmal Nocturnal Hemoglobinuria | Phase 2 | Status: RECRUITING